Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of dostarlimab treatment before surgery in patients with stage II-III endometrial cancer with specific genetic markers

    Recruiting

    1 1 1
    Investigated drugs:
    Spain
  • Study of etentamig and iberdomide treatment for patients with relapsed or refractory multiple myeloma

    Recruiting

    1 1
    Investigated drugs:
    France The Netherlands Norway
  • Study of nadofaragene firadenovec alone or with gemcitabine, docetaxel or pembrolizumab in adults with non-muscle invasive bladder cancer who did not respond to BCG therapy

    Recruiting

    1 1 1 1
    Investigated diseases:
    Czechia Denmark France Poland Spain
  • Study of Tarlatamab and Temozolomide combination treatment in adolescents and adults with high grade brain tumors

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of Faricimab treatment to improve vision in patients with diabetic macular edema using adaptive optics imaging

    Recruiting

    1 1 1 1
    Investigated drugs:
    Germany
  • Study of loncastuximab tesirine and epcoritamab combination treatment for patients with relapsed or refractory diffuse large B-cell lymphoma

    Recruiting

    1 1 1
    Germany
  • Study comparing tadalafil with ambrisentan versus tadalafil alone in newly diagnosed patients with pulmonary arterial hypertension who have cardiovascular conditions

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of drug combination therapy after surgery in patients with resectable pancreatic ductal adenocarcinoma using lab-grown mini-tumors to guide treatment selection

    Recruiting

    1 1 1
    Investigated diseases:
    Germany
  • Study of Intravenous Sodium Thiosulfate for Treatment of Primary Raynaud’s Phenomenon

    Recruiting

    1 1 1
    The Netherlands
  • Study of encorafenib and cetuximab treatment for patients with BRAF V600E-mutant metastatic colorectal cancer who previously responded to BRAF inhibitor therapy

    Recruiting

    1 1 1
    Investigated drugs:
    Spain